Lobbying activity

4T

HORIZON GOVERNMENT AFFAIRS for PHRMA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues

View → 2A

HARNED STRATEGIES LLC for JOB CREATORS NETWORK

2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate · $7,500.00 income

Small Business, Taxation/Internal Revenue Code, Unemployment, Budget/Appropriations

View → Q3

HARNED STRATEGIES LLC for JOB CREATORS NETWORK

3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate · $6,000.00 income

Government Issues, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations

View → 3A

LUNDBECK LLC for LUNDBECK LLC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Trade (domestic/foreign), Health Issues, Medicare/Medicaid

View → Q3

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues

View → Q3

TODD STRATEGY GROUP for NOVARTIS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q3

EMD SERONO, INC. for EMD SERONO INC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → 3A

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Agriculture, Energy/Nuclear, Budget/Appropriations, Copyright/Patent/Trademark

View → Q3

LUNDBECK LLC for LUNDBECK LLC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q3

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View → Q3

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Agriculture, Tariff (miscellaneous tariff bills), Budget/Appropriations, Copyright/Patent/Trademark

View → Q3

DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Defense, Trade (domestic/foreign), Copyright/Patent/Trademark, Pharmacy

View → Q3

NOVARTIS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q3

WILLIAMS AND JENSEN, PLLC for PHRMA

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Trade (domestic/foreign), Medicare/Medicaid, Health Issues, Budget/Appropriations

View → Q3

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate

Taxation/Internal Revenue Code, Veterans, Trade (domestic/foreign), Health Issues

View → Q3

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Pharmacy

View → Q3

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q3

NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate

Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code

View → Q3

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues

View → Q3

DLA PIPER LLP (US) for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues

View → Q3

PUBLIC CITIZEN for PUBLIC CITIZEN

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Constitution

View → Q3

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Health Issues, Budget/Appropriations

View → Q3

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income

Medicare/Medicaid, Pharmacy

View → Q3

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q3

FORBES-TATE for NOVARTIS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Taxation/Internal Revenue Code, Trade (domestic/foreign), Budget/Appropriations, Copyright/Patent/Trademark

View →